NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/22/2026
Back to search
Official data from USPTO
GUIDED THERAPY DOLORCLAST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
01/23/2026
Trademark type
Combined
Nice classes
3, 5, 10, 44
Filing date
04/13/2021
Registration date
01/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2024
Last transaction
01/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CH
Examiner
MCGILL, CIERRA L
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the following: a white circle with a black border containing the words "GUIDED DOLORCLAST THERAPY" appearing inside. The words "GUIDED" and "THERAPY" are black, and the word "DOLORCLAST" is red.
Holders and representatives
Holders
Ferton Holding S.A.
EMS Electro Medical Systems GmbH
Representatives
Michelle P. Ciotola Cantor Colburn LLP
Technical classification
Nice Classes
Class 3Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Non-medicated skin creams; non-medicated hand lotions; non-medicated body creams; body gels in the nature of skin care preparationskin moisturizing gelshaving gelaloe vera gel for cosmetic purposesmassage gels other than for medical purposes; body lotions; cosmetics; moisturizing body lotions
Class 5
Aloe vera gel for therapeutic purposes; antibacterial alcohol skin sanitizer gels; chemical preparations for medical purposesnamely for the treatment of musculoskeletal disorders; diagnostic agents for medical use; pharmaceutical moisturizing body lotion; gels for dermatological use; topical gels for medical and therapeutic usenamely ultrasound gel; contrast media for use with medical ultrasound apparatus; medicated body gels for pharmaceutical use in the nature of medicated skin care preparations; massage gels for medical purposes; medicated skin lotions; medicated body gels in the nature of medicated skin care preparations; medicated lotions for treating dermatological conditions; medicinal oils; lotions for pharmaceutical purposesnamely antivirals; veterinary preparationsnamely antioxidants; sanitary sterilizing preparations; diagnostic preparations for medical purposes; ultrasound gel for medical use; oils for dermatological usenamely oils containing vitamins and minerals for dermatological use
Class 10
Surgical apparatus and instruments for medicaldental and veterinary use; electro medical apparatus for the application of shock waves and pressure pulses in the treatment of musculoskeletal disorders
Class 44
Medical services; mental health services; beauty care services for humans
Publications
History of USPTO decisions and trademark events.
43 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/22/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/03/2024
FIMP
FINAL DISPOSITION PROCESSED
04/02/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/02/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/17/2023
PUBO
PUBLISHED FOR OPPOSITION
10/17/2023
GPNX
NOTIFICATION PROCESSED BY IB
10/16/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/27/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/07/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/13/2023
GNFR
FINAL REFUSAL E-MAILED
03/13/2023
CNFR
FINAL REFUSAL WRITTEN
03/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/28/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/27/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/08/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/21/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/21/2022
RFNP
REFUSAL PROCESSED BY IB
09/05/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/09/2022
GNRT
NON-FINAL ACTION E-MAILED
08/09/2022
CNRT
NON-FINAL ACTION WRITTEN
08/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/06/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
02/25/2022
RFNT
REFUSAL PROCESSED BY IB
02/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/11/2022
RFRR
REFUSAL PROCESSED BY MPU
01/11/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/19/2021
CNRT
NON-FINAL ACTION WRITTEN
12/18/2021
DOCK
ASSIGNED TO EXAMINER
12/04/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/20/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/16/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/15/2021
Continuous trademark protection
Get notified about every new filing that threatens GUIDED THERAPY DOLORCLAST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.